Chargement en cours...
Host-targeting therapies for hepatitis C virus infection: current developments and future applications
Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) worldwide. In the past few years, anti-HCV therapies have undergone a revolution with the approval of multiple direct-acting antivirals (DAAs), which enable interferon-free treat...
Enregistré dans:
| Publié dans: | Therap Adv Gastroenterol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5871046/ https://ncbi.nlm.nih.gov/pubmed/29619090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284818759483 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|